Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Evaluation of a new recombinant DNA hepatitis B vaccine (Shanvac-B)

By Abraham P.   Mistry F.P.   Bapat M.R.   Sharma G.   Reddy G.R.   Prasad K.S.N.   Ramanna V.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1125-1129

Elsevier

Access to resources Recommend Favorite

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine

By Watson B.   West D.J.   Chilkatowsky A.   Piercy S.   Ioli V.A.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3164-3168

Elsevier

Access to resources Recommend Favorite

Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

By Schreuder M.P.   Deen C.   Boersma W.J.A.   Pouwels P.H.   Klis F.M.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity

By Chiaramonte M.   Majori S.   Ngatchu T.   Moschen M.E.   Baldo V.   Renzulli G.   Simoncello I.   Rocco S.   Bertin T.   Naccarato R.   Trivello R.  

Vaccine, Vol. 14, Iss. 2, 1996-02 ,pp. : 135-137

Elsevier

Access to resources Recommend Favorite